Growing clinical and preclinical evidence, indeed, reveals that there is a relationship between the altered degradation of misfolded proteins, such as amyloid β (Aβ) peptides and hyperphosphorylated tau protein, and the pathogenesis of AD [15,16]. The gene discussed is MAPT; the disease is Alzheimer disease.